Axxam Enters Into Research Collaboration with Sanofi in the Field of Neurodegeneration

September 5 2017 – Milan (Italy) – Axxam S.p.A today announced the start of a research collaboration with Sanofi designed to further optimize a number of lead series of small molecules targeted against a range of diseases of the central nervous system (CNS).

Open PDF document